Tilray Brands, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated July 12, 2022, details the closing of a transaction previously announced by Tilray Brands, Inc. (Tilray). The transaction involves the acquisition of a secured convertible note issued by HEXO Corp. (HEXO) from HT Investments MA LLC (HTI). The closing date for the transaction was July 12, 2022.
Key Financial Metrics and Transaction Details
The filing does not report standard operating metrics such as revenue, profit, or cash flow for a specific period. Instead, it outlines the financial terms of the transaction:
- Total Purchase Price: $154,940,400 for the HEXO Note (outstanding principal balance less a 10.8% discount).
- Consideration Paid by Tilray:
- Debt: A newly issued $50 million convertible promissory note (Tilray Convertible Note).
- Equity: 33,314,412 shares of Tilray Class 2 common stock.
- Tilray Convertible Note Terms:
- Interest Rate: 4.0% per annum.
- Maturity Date: September 1, 2023.
- Conversion Price: 125% of the closing sale price on the Closing Date.
- Conversion Cap: Limited to 20,000,000 shares of Common Stock.
- HEXO Note Terms (Acquired by Tilray):
- Interest Rate: 5.0% per annum.
- Maturity Date: May 1, 2026.
- Conversion Price: Initial price of CAN$0.40 per HEXO common share.
Material Changes and Commercial Agreements
Upon closing, Tilray and HEXO entered into several commercial agreements:
- Advisory Services: Tilray will provide advisory services to HEXO for an annual fee of $18 million.
- Co-Manufacturing: An agreement for third-party manufacturing services and international bulk supply from Tilray to HEXO.
- Procurement and Cost Savings: An agreement to share savings from optimization activities and procurement.
- Board Representation: Tilray is entitled to appoint two directors and one observer to the HEXO board of directors. Denise Faltischek and Roger Savell were appointed as directors effective July 12, 2022.
Guidance, Risks, and Contingencies
The filing does not provide updated financial guidance or outlook for Tilray's core operations. Key risks and contingencies associated with the transaction include:
- Dividend Restrictions: Tilray is prohibited from declaring or paying dividends on its capital stock without the prior written consent of HTI while the Tilray Convertible Note is outstanding.
- Change of Control: In the event of a change of control prior to maturity, HTI has the right to require immediate redemption of the Tilray Convertible Note at 105% of the outstanding principal plus accrued interest.
- Equity Conditions: Tilray's ability to repay the Tilray Convertible Note in shares at maturity is contingent upon maintaining listing status on The Nasdaq Global Market and meeting specific minimum average price and trading volume requirements.
- Post-Closing Adjustment: The number of shares issued to HTI is subject to a post-closing adjustment based on the 44-trading day VWAP following the Closing Date.
Investor Verification Checklist
- Verify the impact of the $50 million Tilray Convertible Note on the company's debt-to-equity ratio and liquidity position.
- Confirm the dilution effect of the 33,314,412 shares issued to HTI and the potential for additional shares via the post-closing adjustment or conversion.
- Review the $18 million annual advisory fee commitment and its impact on future operating expenses.
- Assess the strategic value of the board seats and commercial agreements with HEXO relative to the cost of the transaction.
- Monitor Tilray's stock price and trading volume to ensure compliance with the equity conditions required for share-based repayment of the Tilray Convertible Note.